OncoPharm cover image

Lirafugratinib + LITESPARK011

OncoPharm

00:00

Quality Of Life Does Not Improve

John Bazar reviews patient-reported outcomes showing no significant quality-of-life advantage for lenvatinib plus belzutifan over cabozantinib.

Play episode from 12:32
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app